4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-026470
Acting Chief Business Officer sold 20,000 shares at an average $15.18 ($303,593)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Savill Corrine Acting Chief Business Officer | 2022-07-18 | Sale | −5,042 | $15.06 | $75,933 | 164,573 | D: show line 1 in the form |
| Savill Corrine Acting Chief Business Officer | 2022-07-19 | Sale | −14,958 | $15.22 | $227,661 | 149,615 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $15.18 · $303,593 | |||||||
Loading xslF345X03/doc4.xml…